Caterpillar Inc. (NEO:CATR)

Ligand Pharmaceuticals Revenue

Caterpillar had revenue of $16.57B USD in the quarter ending June 30, 2025, a decrease of -0.72%. This brings the company's revenue in the last twelve months to $63.14B, down -4.87% year-over-year. In the year 2024, Caterpillar had annual revenue of $64.81B, down -3.36%.

• Revenue (ttm): $63.14B
• Revenue Growth: -4.87%
• P/S Ratio: 3.12
• Revenue / Employee: $559.25K
• Employees: 112,900
• Market Cap: 268.28B

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	64.81B	-2.25B	-3.36%
Dec 31, 2023	67.06B	7.63B	12.84%
Dec 31, 2022	59.43B	8.46B	16.59%
Dec 31, 2021	50.97B	9.22B	22.09%
Dec 31, 2020	41.75B	-12.05B	-22.40%